Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
16.72
-0.33 (-1.94%)
At close: Jun 26, 2026, 4:00 PM EDT
16.77
+0.05 (0.30%)
After-hours: Jun 26, 2026, 4:10 PM EDT

AAPG Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, AAPG stock has a consensus rating of "Strong Buy" and an average price target of $47.56. The average 1-year stock price forecast is 184.45% higher than the current stock price, while the lowest is $40 (+139.23%) and the highest is $55 (+228.95%).

Price Target: $47.56 (+184.45%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$40$47.56$48$55
Change+139.23%+184.45%+187.08%+228.95%

Analyst Ratings

The average analyst rating for AAPG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy545667
Buy222222
Hold000000
Sell000000
Strong Sell000000
Total767889

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Oppenheimer
Oppenheimer
Buy
Initiates
$45
BuyInitiates$45+169.14%Jun 15, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$45
BuyInitiates$45+169.14%Jun 10, 2026
Piper Sandler
Piper Sandler
Buy
Maintains
$48
BuyMaintains$48+187.08%Jun 1, 2026
BTIG
BTIG
Buy
Maintains
$48
BuyMaintains$48+187.08%May 14, 2026
Truist Financial
Truist Financial
Buy
Maintains
$51$22
BuyMaintains$51$22+33.61%Apr 24, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
861.41M
from 574.12M
Increased by 50.04%
Revenue Next Year
1.48B
from 861.41M
Increased by 72.13%
EPS This Year
-2.71
from -3.49
EPS Next Year
-0.77
from -2.71
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
27.91M209.71M221.98M980.65M574.12M861.41M
Revenue Growth
124.18%651.38%5.85%341.77%-41.46%50.04%
Gross Profit
24.58M187.71M191.44M951.57M525.18M778.80M
Gross Margin
88.08%89.51%86.24%97.03%91.48%90.41%
Operating Income
-933.17M-883.41M-891.99M-378.80M-1.21B-889.22M
Net Income
-782.42M-882.92M-925.64M-405.43M-1.24B-902.59M
EPS
-----3.49-2.71
Free Cash Flow
-954.65M-680.98M-706.12M-81.25M-942.63M-946.43M
No. Analysts
-----11
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High1.2B
Avg861.4M
Low608.9M

Revenue Growth

Revenue Growth202620272028
High
110.6%
Avg
50.0%
Low
6.1%

EPS Forecast

EPS202620272028
High-1.50
Avg-2.71
Low-3.80

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-